CLRB
Price
$2.31
Change
-$0.06 (-2.53%)
Updated
Sep 11 closing price
Capitalization
21.83M
47 days until earnings call
Intraday BUY SELL Signals
GOVX
Price
$0.46
Change
-$0.01 (-2.13%)
Updated
Sep 11 closing price
Capitalization
4.21M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLRB vs GOVX

CLRB vs GOVX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLRB vs. GOVX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a StrongBuy and GOVX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRB($21.8M) has a higher market cap than GOVX($4.21M). CLRB YTD gains are higher at: -21.695 vs. GOVX (-89.170). GOVX has higher annual earnings (EBITDA): -20.3M vs. CLRB (-23.5M). CLRB has more cash in the bank: 34M vs. GOVX (3.14M). GOVX has less debt than CLRB: GOVX (323K) vs CLRB (1.53M). CLRB (0) and GOVX (0) have equivalent revenues.
CLRBGOVXCLRB / GOVX
Capitalization21.8M4.21M518%
EBITDA-23.5M-20.3M116%
Gain YTD-21.695-89.17024%
P/E RatioN/AN/A-
Revenue00-
Total Cash34M3.14M1,082%
Total Debt1.53M323K474%
FUNDAMENTALS RATINGS
CLRB vs GOVX: Fundamental Ratings
CLRB
GOVX
OUTLOOK RATING
1..100
5981
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6495
P/E GROWTH RATING
1..100
64100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOVX's Valuation (22) in the null industry is somewhat better than the same rating for CLRB (75) in the Biotechnology industry. This means that GOVX’s stock grew somewhat faster than CLRB’s over the last 12 months.

GOVX's Profit vs Risk Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that GOVX’s stock grew similarly to CLRB’s over the last 12 months.

CLRB's SMR Rating (99) in the Biotechnology industry is in the same range as GOVX (100) in the null industry. This means that CLRB’s stock grew similarly to GOVX’s over the last 12 months.

CLRB's Price Growth Rating (64) in the Biotechnology industry is in the same range as GOVX (95) in the null industry. This means that CLRB’s stock grew similarly to GOVX’s over the last 12 months.

CLRB's P/E Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for GOVX (100) in the null industry. This means that CLRB’s stock grew somewhat faster than GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBGOVX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (CLRB: $2.31 vs. GOVX: $0.46)
Brand notoriety: CLRB and GOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 107% vs. GOVX: 28%
Market capitalization -- CLRB: $21.83M vs. GOVX: $4.21M
CLRB [@Biotechnology] is valued at $21.83M. GOVX’s [@Biotechnology] market capitalization is $4.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green while GOVX’s FA Score has 1 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • GOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, GOVX is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 5 TA indicator(s) are bullish while GOVX’s TA Score has 4 bullish TA indicator(s).

  • CLRB’s TA Score: 5 bullish, 5 bearish.
  • GOVX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CLRB and GOVX are a good buy in the short-term.

Price Growth

CLRB (@Biotechnology) experienced а -2.53% price change this week, while GOVX (@Biotechnology) price change was -4.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CLRB is expected to report earnings on Oct 29, 2026.

GOVX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CLRB
Daily Signal:
Gain/Loss:
GOVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMR1.350.03
+2.27%
Beamr Imaging Ltd
IMMR7.400.04
+0.54%
Immersion Corp
PNC244.241.26
+0.52%
PNC Financial Services Group
LGND284.47-4.78
-1.65%
Ligand Pharmaceuticals
GLUE14.07-0.25
-1.75%
Monte Rosa Therapeutics

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with QTTB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
-2.53%
QTTB - CLRB
62%
Loosely correlated
+3.54%
ADCT - CLRB
43%
Loosely correlated
-3.60%
RKTO - CLRB
42%
Loosely correlated
-0.73%
OGEN - CLRB
41%
Loosely correlated
-5.03%
ANAB - CLRB
40%
Loosely correlated
-2.34%
More